Among all 314 screened patients, 284 were successfully tested for HER2 overexpression by IHC (69 patients with UBC, 133 with pancreatic cancer, and 82 with cholangiocarcinoma). The gene discussed is ERBB2; the disease is familial pancreatic carcinoma.